Email Updates

Home

Achieving
the
End of AIDS

Achieving
the
End of
AIDS

Learn more

The world is talking about ending AIDS. AVAC’s advocacy is dedicated to realizing that vision. To get there we must:

  • Deliver proven tools for immediate impacts.
  • Demonstrate and roll out new HIV prevention tools.
  • Develop long-term solutions to end the epidemic.

Learn more

Spotlight

  • October 14, 2020

    Updates to AVAC’s Global PrEP Tracker are in for Q3 2020, showing that overall global uptake continued to climb even in the midst of COVID-19. The number of people who have started on PrEP has reached 773,474, an increase of more than 23 percent since the year began. This figure includes countries where the burden of HIV is high, such as Kenya and South Africa, and despite the impact of COVID-19 on healthcare systems.

  • September 24, 2020

    COVID-19 has devastated communities and health systems around the world – but it has also created an historic global effort leading to the unprecedented development of more than 165 potential vaccines against COVID-19. Equally impressive innovations are speeding vaccine testing within a rigorous scientific framework, while manufacturing and transportation capacity are being scaled up to distribute millions of doses of future COVID vaccines to those who need them most.

  • October 14, 2020

    Developing COVID-19 vaccines at “pandemic speed” depends on an unprecedented global research effort and on innovative strategies to shorten the vaccine testing and distribution timeline. Speed is important, but not at the expense of ethics, safety, robust engagement, equitable access and scientific rigor.

  • September 24, 2020

    The latest estimates for COVID-19 anticipate a death toll approaching 2.8 million by year’s end. Global health leaders of every stripe struggle to sustain the gains against HIV, TB, malaria, other preventable diseases and unintended pregnancies. Advocates must be armed with information and tools to demand transparency, and to get effective interventions for both HIV and COVID-19 developed and distributed equitably. Read on for recently produced resources to help get the job done.

Find Resources

AVAC has an extensive online resource library with hundreds of Reports, Publications, Infographics & more. And it includes powerful search features to find exactly what you’re looking for.

What We Do

AVAC uses education, policy analysis, advocacy, community mobilization and a network of global collaborations to accelerate ethical development and global delivery of biomedical HIV prevention options. Read more

Px Methods

AVAC advocates for a comprehensive response to the epidemic, involving smart use of every proven HIV prevention option available today and sustained research into many new strategies.